![](/img/cover-not-exists.png)
Effects of Liraglutide 3.0 mg and 1.8 mg on Body Weight and Cardiometabolic Risk Factors in Adults with Overweight or Obesity and Type 2 Diabetes (T2D): The SCALE Diabetes Randomized, Double-Blind, Placebo-Controlled, 56-Week Trial
Pedersen, Sue, DeFronzo, Ralph A., Bergenstal, Richard, Bode, Bruce, Kushner, Robert, Lewin, Andrew, Noctor, Maureen, Boras, Damir, Davies, MelanieVolume:
39
Language:
english
Journal:
Canadian Journal of Diabetes
DOI:
10.1016/j.jcjd.2015.01.141
Date:
April, 2015
File:
PDF, 65 KB
english, 2015